0725 GMT [Dow Jones]--UBS says Reed Elsevier (REN.AE) is making progress with its 1H earnings with almost every unit, including EPS, organic revenue growth and Ebita, beating meaningfully. No upgrades, but no downgrades either, says analyst. Rates stock at buy. Shares +3.5% at EUR9.91. ([email protected]) Contact us in London. +44-20-7842-9464 [email protected] (END) Dow Jones Newswires July 29, 2010 03:25 ET (07:25 GMT)